Gene Transfer in Endothelial Dysfunction and Hypertension.

Sabyasachi Sen, Padraig M. Strappe, Timothy O'Brien

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gene transfer represents a method for treatment of several cardiovascular disorders, including endothelial dysfunction and hypertension. For effective and safe gene therapy in vascular disease, a suitable therapeutic gene needs to be identified and delivered to the vasculature by appropriate delivery devices. In this chapter, we review the different vectors used, both viral and nonviral, suitable genes identified, and associated delivery devices. Several genes have been identified with a view to improve endothelial dysfunction, and we have elaborated the advantages and disadvantages of these approaches. Strategies to treat hypertension, both systemic and pulmonary, have also been described. The optimal vector has not yet been discovered although a wide variety of choices is available, each with properties that may render it suitable for specific applications. The individual characteristics of these vectors are described in relation to the proposed therapeutic paradigm. Although there are several unanswered questions in this arena, the future application of gene transfer technology to diseases of the vasculature holds significant promise.
Original languageEnglish
Pages (from-to)299-314
Number of pages16
JournalMethods in Molecular Medicine
Volume108
Issue numberPart V
DOIs
Publication statusPublished - 2005

Fingerprint

Hypertension
Genes
Technology Transfer
Equipment and Supplies
Vascular Diseases
Genetic Therapy
Therapeutics
Lung

Cite this

Sen, Sabyasachi ; Strappe, Padraig M. ; O'Brien, Timothy. / Gene Transfer in Endothelial Dysfunction and Hypertension. In: Methods in Molecular Medicine. 2005 ; Vol. 108, No. Part V. pp. 299-314.
@article{d58dbc9c11d14c849136166b7dbb1b09,
title = "Gene Transfer in Endothelial Dysfunction and Hypertension.",
abstract = "Gene transfer represents a method for treatment of several cardiovascular disorders, including endothelial dysfunction and hypertension. For effective and safe gene therapy in vascular disease, a suitable therapeutic gene needs to be identified and delivered to the vasculature by appropriate delivery devices. In this chapter, we review the different vectors used, both viral and nonviral, suitable genes identified, and associated delivery devices. Several genes have been identified with a view to improve endothelial dysfunction, and we have elaborated the advantages and disadvantages of these approaches. Strategies to treat hypertension, both systemic and pulmonary, have also been described. The optimal vector has not yet been discovered although a wide variety of choices is available, each with properties that may render it suitable for specific applications. The individual characteristics of these vectors are described in relation to the proposed therapeutic paradigm. Although there are several unanswered questions in this arena, the future application of gene transfer technology to diseases of the vasculature holds significant promise.",
author = "Sabyasachi Sen and Strappe, {Padraig M.} and Timothy O'Brien",
note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Methods in Molecular Medicine. ISSNs: 1543-1894;",
year = "2005",
doi = "10.1385/1-59259-850-1:299",
language = "English",
volume = "108",
pages = "299--314",
journal = "Methods in Molecular Medicine",
issn = "1543-1894",
publisher = "Humana Press",
number = "Part V",

}

Gene Transfer in Endothelial Dysfunction and Hypertension. / Sen, Sabyasachi; Strappe, Padraig M.; O'Brien, Timothy.

In: Methods in Molecular Medicine, Vol. 108, No. Part V, 2005, p. 299-314.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gene Transfer in Endothelial Dysfunction and Hypertension.

AU - Sen, Sabyasachi

AU - Strappe, Padraig M.

AU - O'Brien, Timothy

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Methods in Molecular Medicine. ISSNs: 1543-1894;

PY - 2005

Y1 - 2005

N2 - Gene transfer represents a method for treatment of several cardiovascular disorders, including endothelial dysfunction and hypertension. For effective and safe gene therapy in vascular disease, a suitable therapeutic gene needs to be identified and delivered to the vasculature by appropriate delivery devices. In this chapter, we review the different vectors used, both viral and nonviral, suitable genes identified, and associated delivery devices. Several genes have been identified with a view to improve endothelial dysfunction, and we have elaborated the advantages and disadvantages of these approaches. Strategies to treat hypertension, both systemic and pulmonary, have also been described. The optimal vector has not yet been discovered although a wide variety of choices is available, each with properties that may render it suitable for specific applications. The individual characteristics of these vectors are described in relation to the proposed therapeutic paradigm. Although there are several unanswered questions in this arena, the future application of gene transfer technology to diseases of the vasculature holds significant promise.

AB - Gene transfer represents a method for treatment of several cardiovascular disorders, including endothelial dysfunction and hypertension. For effective and safe gene therapy in vascular disease, a suitable therapeutic gene needs to be identified and delivered to the vasculature by appropriate delivery devices. In this chapter, we review the different vectors used, both viral and nonviral, suitable genes identified, and associated delivery devices. Several genes have been identified with a view to improve endothelial dysfunction, and we have elaborated the advantages and disadvantages of these approaches. Strategies to treat hypertension, both systemic and pulmonary, have also been described. The optimal vector has not yet been discovered although a wide variety of choices is available, each with properties that may render it suitable for specific applications. The individual characteristics of these vectors are described in relation to the proposed therapeutic paradigm. Although there are several unanswered questions in this arena, the future application of gene transfer technology to diseases of the vasculature holds significant promise.

U2 - 10.1385/1-59259-850-1:299

DO - 10.1385/1-59259-850-1:299

M3 - Article

VL - 108

SP - 299

EP - 314

JO - Methods in Molecular Medicine

JF - Methods in Molecular Medicine

SN - 1543-1894

IS - Part V

ER -